A new line of marijuana growing kits for home use has been launched by Avail Vapor, one of the largest vaping companies in the world. Avail’s cannabis kits started to be sold in 18 of its Virginia-based stores under the Avail Grow brand on July 1, according to Maggie Gowen, Avail’s senior director of marketing and communications. Avail’s marijuana growing supplies will be available only in-store and not online.
The growing kits feature soil, nutrients, lamps and other equipment needed to grow marijuana in Virginia, where marijuana became legal on July 1. The kits do not offer seeds, however. The sale of marijuana seeds and plants are illegal in Virginia. Residents over the age of 21 in Virginia are allowed to have up to four marijuana plants per household.
Priced at $130, the Starter Kit is intended to be used from germination through the seedling phase. Two additional kits are being offered by Avail Grow for $600 and $800 that will bring the plants to the harvesting stage. The larger kits also offer tenting and a filtration system.
Avail Grow is the vapor manufacturers second foray into the cannabis market. Avail launched its Leafana Wellness line of cannabidiol (CBD) products in 2019. Early last year, Avail Vapor split into three separate entities: Avail Vapor LLC (retail), Blackbriar Regulatory Services (contract manufacturing, laboratory services and FDA compliance consulting) and Blackship Technologies LLC (research and development).
Large companies may soon dominate the U.S. vapor market while e-cigarettes produced by smaller companies may disappear, according to new research by ECigIntelligence.
Analysis of FDA premarket tobacco product applications (PMTAs) shows that more applications for simpler disposables and cigalike devices were submitted than applications for open systems. According to ECigIntelligence, the simpler products usually come from large companies while the open systems usually come from smaller businesses.
Only about 30 open system brands have filed PMTAs, implying that 85 percent of open system brands will be removed from the market, even if all 30 filed PMTAs are approved.
“This may indicate the discouragement nontobacco companies face when applying for PMTA approval,” said ECigIntelligence Managing Director Tim Phillips. “The PMTA process can be a grueling one for nontobacco companies without sufficient financial means or knowhow. And if smaller brands are to become less prevalent in this category, consumers may soon only have the option of a few models provided by a handful of big companies.”
If you are struggling to work out whether you and your fellow human beings will be able to save the only planet on which we can live from being made uninhabitable by climate change, it is possibly because you are looking in the wrong direction for the answer—you are looking at the data, which, because it comprises complex inputs from many interacting sciences, is impossible for a layperson to interpret.
But never mind; I have cut through all this data for you and come to a conclusion that I believe is rock solid. No, we won’t save the world.
And to become a fellow believer, you need look no further for evidence than the existence of the powered leaf blower. That people, with the possible exception of the disabled, buy these things rather than brooms during a climate emergency engendered largely by the overuse of unrenewable energy provides indisputable evidence that humans refuse to engage their brains and, therefore, won’t—and probably shouldn’t—survive.
There is a man of my acquaintance who uses a powered blower to corral the leaves in his garden, which is the size only of one of those large, starched napkins beloved, for good reason, of spaghetti eaters, and at the front of his house, including the pavement, which forms a larger area.
It is fascinating to watch him because, like a dog rounding up sheep, he has to keep going back for stragglers, which are often stragglers only because they have been hit by a puff of wind, possibly caused, in part, by climate change, which, in turn, is being exacerbated by the use of the leaf blower …
But his offense is worse than this because, after corralling his leaves, he gets into his car, which is not much smaller than a bus capable of carrying half a dozen people and all their worldly goods, and drives off, alone, to the gym, contributing as he goes to the already high and probably illegal levels of pollution we happily maintain in these parts.
He could have obtained a good level of exercise by wielding a broom at those leaves, but no, he prefers to burn fossil fuels driving down to the gym where he mounts an exercise machine manufactured using huge amounts of energy and materials dug out of the ground or manufactured so as to be, like Tithonus, cursed with an immortality not mitigated by eternal youth.
At least you would think that the machine he mounts would be connected to the gym’s power supply so that the work he does has some purpose. But no, this is a lesson in entropy, so the work he does is converted into heat that causes the gym’s air-conditioning system to kick in, burning more energy …
And as my acquaintance works on his machine, happily watching his pain and discomfort reflected back at him by giant mirrors, keenly monitoring on his wrist-mounted electronic device the state of organs whose position in his body he couldn’t identify, and listening distractedly to music delivered through sweat-encrusted headphones, his wife is vacuuming the house—getting rid of the dust that, in no small part, comprises small leaf particles created and driven into the air by the actions of her husband and his leaf blower.
Is this sensible? Of course, I admit that, even though there are a lot of people like my acquaintance and his wife, to a certain extent, what individuals can do to help ameliorate the climate emergency is a drop in the ocean compared with what could be done by businesses, industries and governments, but I think the situation would be helped if individuals showed a greater awareness of the problems we face and the sorts of actions that are plain stupid if the aim is to save the planet.
In that way, perhaps, they would be in a better position and more likely to put pressure on businesses, industries and governments to take action. After all, it would be awful to go out with a whimper.
There is no point in expecting politicians to act logically without their being pressured to do so because, as somebody nearly once said, people are governed by parliaments, not by logic. Unfortunately, we in the tobacco and nicotine industries are similarly governed—not by logic, but by governments largely swayed by half-baked ideas delivered by lobbyists, broken economic systems and pollsters, not to mention great dollops of hypocrisy.
So my eye was caught recently by the heading of a May 7 story by Sarantis Michalopoulos for EURACTIV.com based on an interview with Michele Rivasi, who was described as a French EU lawmaker from the group of the Greens/European Free Alliance (Europe Ecologie) of the European Parliament, MEP: E-cigarettes have a place in the EU Cancer Plan, but we must remain vigilant. Given this was a report based on an interview with a Green politician, I was keen to read it because I am interested in the environmental credentials of e-cigarettes, a subject that doesn’t seem to attract enough debate.
However, I was disappointed. This was another of those fence-sitting exercises in which the risk-reduction characteristics of e-cigarettes are acknowledged but in which it is said that nothing should be done to encourage their use, which seems to miss the point that if their use isn’t encouraged, then their risk-reduction potential remains hanging in limbo.
“E-cigarettes ‘undoubtedly’ reduce risks compared to traditional cigarettes and have a place in the EU’s plan to fight cancer,” Michalopoulos quotes Rivasi as saying. “However, these products should not enjoy ‘lighter’ regulation, and Europe should treat them with the same vigilance as tobacco products. I see no reason why the electronic cigarette and its products should benefit from tax reductions or exemptions.”
What is being said here? Well, as I read it, nothing helpful or rational. Rivasi seems to be saying that traditional cigarettes and e-cigarettes are, at one and the same time, different but the same. These products are so different that e-cigarettes can be seen as part of the weaponry with which to fight cancer, whereas traditional cigarettes comprise part of cancer’s own armory. But, at the same time, they are so similar that they should be treated the same when it comes to regulations and taxes.
You have to wonder what Rivasi believes smokers will make of such a stance, if indeed it can be regarded as a stance. Most smokers, I imagine, make some kind of compromise in moving from traditional cigarettes to e-cigarettes, perhaps in respect of satisfaction, taste, convenience … Even so, in the early days of e-cigarettes, it was probably relatively easy to get smokers to convert because many of them were willing to make compromises simply on the basis that they were moving to a less risky product.
Now, in those countries where a significant level of conversion has taken place, it becomes necessary to try to reduce the compromises that must be made and, in this way, encourage more-committed smokers to convert. Tobacco and nicotine businesses tend to do this simply because they are in competition; they want their products to be more satisfying, tasty and convenient than those of their competitors.
But an important way of reducing the compromises that have to be made is through price—i.e., tax—differentials or through regulation, such as that allowing the use of e-cigarettes in at least some public places where traditional cigarettes may not be smoked. Lumping together traditional cigarettes and e-cigarettes in respect of taxation and regulation is simply ridiculous if the aim is to get smokers to transition to vaping. It sends out a signal that e-cigarettes do not offer a real health benefit.
Rivasi has more to say on products that to her way of thinking are similar. “For us, the Greens, if the use of electronic cigarettes is claimed to be an alternative to tobacco [use], as a substitute product or as a way of reducing the ravages associated with conventional cigarettes … we need to consider electronic cigarettes as a medical device in the same way as gum or patches are pharmaceutical products,” Michalopoulos reports Rivasi as saying.
I’m not sure whether a distinction is being made here between a medical device and a pharmaceutical product, but I assume not. So what seems to be being said is that if e-cigarettes are claimed to be a substitute for or alternative to traditional cigarettes, they should be treated as if they are nicotine-replacement products (NRTs), an idea that seems to ignore the fact that NRTs are not consumer products and therefore cannot be seen as substitutes for or alternatives to traditional cigarettes.
Again, the lack of logic drives you to impossible places. If, as above, it is claimed that NRTs are the same as e-cigarettes, which are the same as tobacco products, you have to assume that all three should be taxed at the same level and subject to the same regulations. So, for instance, people shouldn’t be allowed to wear nicotine patches in enclosed public places.
Quite clearly, this would be ludicrous for a number of reasons, and the problem stems from trying to pretend that different things are the same. Traditional cigarettes and e-cigarettes are two similar but different consumer products, whereas NRTs are medical devices, even though, in the U.K., for instance, they have been licensed for harm reduction rather than just cessation.
During the interview, we get much else that seems to discourage the use of e-cigarettes. We get the EVALI (e-cigarette or vaping use-associated lung injury) distraction and a totally unconvincing passage about what Rivasi sees as the gateway vaping provides to smoking.
Later, she is quoted as saying the shortcomings of legislation concerning heated tobacco and electronic cigarettes are known. “We need better regulation of sales and advertising, a thorough analysis of additives and their cocktail effect, a ban on flavorings and mandatory health warnings to alert nonsmokers to the risks, as is the case for traditional cigarettes,” she is reported as saying.
These are just throwaway lines. What does it mean to talk of “better regulation”? Better regulation to somebody steeped in tobacco harm reduction is going to look a lot different to better regulation as seen by those supporting a quit-or-die agenda while goodness knows what better regulation looks like to somebody perched on the fence.
And what is the point, apart from providing cover for science departments to carry out pointless “research,” in calling for a thorough analysis of additives while at the same time calling for a ban on flavors, which make up a huge proportion of those additives?
Towards the end of the reported interview, Rivasi moves to a favorite of politicians: the attribution to a group of a claim that the group has not made and then the condemnation of that claim. “The electronic cigarette is undoubtedly a product that can reduce risks, but it is not the panacea its followers—and the companies behind them—would have us believe,” she is quoted as saying.
I have never heard people who promote e-cigarette use over traditional cigarette use claiming such a move is a panacea. The panacea quip is another throwaway line and one that needs to be thrown away. Indeed, Rivasi knows as much. Earlier in the interview, she is quoted as saying, “The industry itself acknowledges its ignorance and wants to know more about the real impact of its products.” That doesn’t sound to me to be an industry claiming to have already developed a panacea.
There is something odd here. As I mentioned above, there is no mention in the interview of the area of the e-cigarette debate to which Rivasi could, I assume, make a valuable contribution. How do you compare the environmental impacts of traditional cigarettes, e-cigarettes, other new generation products and NRTs?
The major problem is that politicians often believe they need to fuss around tidying up the lives of smokers and nicotine users without considering the wider picture. They are like my acquaintance and his use of the leaf blower. In fact, I would much sooner hear Rivasi talking about leaf blowers and patio heaters … There is no point in extending by a few years the lives of some smokers if we’re all going to die prematurely of pollution and the effects of climate change.
A study led by the University of California – Los Angeles (UCLA) has found that women who use electronic cigarettes during pregnancy are 33 percent more likely than those who don’t to give birth to low-birthweight infants, according to a press release. Low-birthweight babies — those weighing less than 5.5 pounds — often require specialized medical care and are at greater risk of early-life complications and long-lasting health issues, said Annette Regan, the study’s corresponding author and an adjunct assistant professor of epidemiology at the UCLA Fielding School of Public Health.
Findings from the study, which also involved researchers from the University of San Francisco, Texas A&M University and the U.S. Centers for Disease Control and Prevention, are published online in the journal Obstetrics & Gynecology.
The researchers analyzed data on approximately 80,000 mothers from the 2016–18 Pregnancy Risk Assessment Monitoring System, or PRAMS, a CDC-coordinated project that collects information nationwide on maternal experiences before, during and shortly after pregnancy. Among that cohort, 1.1 percent (800) reported having used e-cigarettes during the final three months of their pregnancy, and nearly two-thirds (533) of those e-cigarette users said they had also combustible cigarettes during that period.
“Although only a small percentage of people used e-cigarettes, we were surprised with how many used both e-cigarettes and combustible cigarettes during pregnancy,” said Regan, who also teaches at the University of San Francisco’s nursing school. “We found increased rates of low birthweight for e-cigarette users, and this occurred even for those who didn’t also smoke cigarettes.”
Beginning in October, Australian businesses will face fines of up to AUS11 million ($8.2 million) if they are caught selling illegal nicotine vaping products. That’s when a strict new set of safety guidelines from the medicines regulator will come into effect for vaping products that are supplied into Australia and are not registered in the Australian Register of Therapeutic Goods. There are currently no nicotine vaping products in the register.
The move comes as part of an overhaul of the country’s vaping regulations. The rules state Australians must have a prescription before buying e-cigarettes and vaping products online from overseas, according to theSydney Morning Herald.
The new quality rules specify that the products must not contain any active ingredients other than nicotine. They also detail set labelling and packaging rules, including warnings to keep the goods out of reach of children. The rules also ban certain flavoring additives such as cinnamaldehyde, which is used to create a cinnamon flavor, and acetonin, which is used to create a creamy flavor.
A Therapeutic Goods Administration (TGA) spokesperson said supplying non-compliant products was a criminal offence and could also result in civil penalties and fines “up to 5,000 penalty units for an individual – up to AUS1,110,000 – and 50,000 penalty units for a corporation – up to AUS11,100,000.”
The federal Department of Health held widespread consultation on the new standards, with advocacy group Quit arguing in its feedback that the regulator should be regularly tracking and updating restricted ingredients in line with new evidence about the risks they might pose. “The TGA will revise the list in Schedule 1 to TGO 110 if and when more evidence becomes available showing that other ingredients used in nicotine vaping products carry demonstrable health risks associated with inhalation,” the TGA spokeswoman said.
Nebraska has seen a spike in vape shop robberies recently as thieves target CBD and Delta-8 THC products. On July 10, in Lincoln, Nebraska, Between 2 and 5 a.m., the Lincoln Police Department (LPD) responded to reports and alarms at two businesses — Cloud 9 Smoke Shop and CBD Remedies — where officers found shattered storefront glass at both locations, according to Officer Luke Bonkiewicz.
The Lincoln Journal Star reports that in both cases, burglars gained entry into the businesses — after causing $500 in damage to each storefront, Bonkiewicz said — and made off with product from inside the shops. The owner of Cloud 9, near 11th and F streets, is still conducting inventory to determine what exactly burglars took. The same is true at CBD Remedies, near Normal Boulevard and South 48th Street, where burglars set off an alarm upon entry at 4:48 a.m. Friday.
The pair of break-ins comes two days after another similar burglary, totaling three in as many days. LPD discovered a broken window at Generation V E-Cigarettes and Vape Bar around 4:30 a.m. Wednesday, where the owner of the business near Holdrege Street and North Cotner Boulevard reported a preliminary loss of $2,000, Officer Erin Spilker said.
The latest three break-ins follow at least two others in recent months that seem to align with those investigated this week. But the uptick that seems to involve the same group of burglars could date further back than this calendar year.
Timothy Goodman, a manager at the Lincoln Vapor location hit by burglars in May, said that break-in was just the latest in a string of six incidents in the last year or more. Goodman said it’s his understanding that every break-in can be linked to the same group.
Goodman, who has worked at Lincoln Vapor for nearly four years, said a group of burglars stole $2,000-$3,000 worth of merchandise in May and have lifted around $16,000 in products from the business in the last year and a half. The majority of products were hardware and cannabis products such as CBD and Delta-8 THC. “It’s frustrating beyond belief,” Goodman said. “I wake up most nights in the middle of the night and check the cameras to make sure nobody got in.”
The U.S. Food and Drug Administration’s process for premarket tobacco product applications (PMTAs) has not been perfect. The regulatory agency has been accused of falsely issuing warning letters, leaving companies off of its list of accepted PMTAs and of having issues with its PMTA filing software.
As of July 9, the FDA has issued 130 warning letters for the marketing of illegal vaping products. The majority of those letters centered on e-liquids produced and sold online by small-sized vape shops. As the FDA continues its blitz, however, there is some confusion as some companies who have submitted PMTAs by the Sept. 9, 2020 deadline have received warning letters.
According to Facebook posts from the American Vaping Manufacturers Association (AVM), at least two companies have received warning letters for products that submitted timely PMTAs. Posts acknowledged that the FDA corrected its mistake in a follow-up letter after receiving complaints from the companies. While the number may be small, it does show that the regulatory agency is overwhelmed by the number of submissions it is reviewing.
The FDA also had recently started listing closeout letters for companies that had responded to warning letters. Recently, however, the agency removed those letters from its website. The FDA offered no explanation for the removal of the closeout letters.
Due to the large volume of PMTAs submitted—the FDA says it received more than 6 million applications— the FDA has stated publicly that it is unlikely that the agency will be able to process all submissions before manufacturers are required to pull their products off the market. A court order requires the FDA to complete review of all submitted PMTAs by Sept. 9, 2021.
If a negative action is taken by the FDA on a PMTA application prior to Sept. 9, 2021, the product must be removed from the market or risk FDA enforcement. If a positive order is issued by the FDA on a product in the lists, the product will be listed on the positive marketing orders page and may continue to be marketed according to the terms specified in the order letter.
There are other issues with the FDA PMTA process, as well. The FDA released its list of products that are legal for sale in the U.S. A total of 360 companies (on the original list) filed PMTAs. However, at least five companies that filed PMTAs were erroneously left off the list, according to posts by Amanda Wheeler of the AVM.
In its own investigation, Vapor Voice found that Humble Juice Co. submitted a timely PMTA, received an acceptance letter and was subsequently misidentified on FDA’s list of approved products. The FDA has corrected the error for Humble. The AVM did not name what companies were left off the list or had falsely received warning letters.
The FDA stressed it has not independently verified the information provided by applicants about the marketing status of their products. In addition, the list excludes entries of products from companies that did not provide information on the current marketing status of their products to the FDA so that the agency could determine whether the existence of the application could be disclosed. It is possible companies were left off the list because they did not respond to the FDA before publication of the list.
Other issues with PMTAs include errors in submitting them electronically. Several companies have complained that the FDA’s software that manufacturers must download in order to submit PMTA data has randomly left out some of files that the companies are uploading. At least two companies that have helped prepare more than 500 PMTAs have acknowledged the issue and have presented the problem to the FDA.
“We did 15 PMTAs for various clients and just all of a sudden had somebody come up and they got a deficiency letter asking for information that was included in their submission. We started looking through it and it’s missing. We then spent a bunch of time going through every single one and found several others that were missing one or two files,” one of the companies that discovered errors told Vapor Voice. “We reached out the FDA, got a basic response … we’re aware of this, we’ll get back to you type of thing. We believe it’s a bug in the agency’s eSubmitter program.”
Because of these issues, some companies are offering free PMTA deficiency reviews for companies that submitted them to the FDA. Delphinus Consulting and Blackbriar Regulatory Services have said they have programs to help companies find faults in their PMTA submissions.
Warning letters are expected to continue to be issued for illegal vapor products as the deadline for FDA action moves closer. The FDA has not said if it intends to ask for an extension on the deadline, however, the U.S. Small Business Administration recently sent a letter to the FDA asking the regulatory agency to request an extension.
The FDA often only lists a few products that a company is selling as illegal in a warning letter. It then states that there may be more, but it is impossible to know if the warnings encompass all the company’s registered products. The agency states that it is the responsibility of the company to only sell products with a submitted PMTA.
Companies that receive warning letters from the FDA have to submit a written response to the letter within 15 working days from the date of receipt describing the company’s corrective actions, including the dates on which it discontinued the violative sale, and/or distribution of the products. They also require the company’s plan for maintaining compliance with the FD&C Act in the future.
A more in-depth analysis of these issues will be in the next issue of Vapor Voice.
Juul Labs paid $51,000 to buy out an entire issue of the American Journal of Health Behavior (AJHB) and make it publicly available, the New York Times reported.
The AJHB’s May/June issue published 11 company-funded studies that promote the health benefits of Juul devices in helping smokers quit traditional tobacco products.
“Electronic nicotine delivery systems (ENDS) represent a significant opportunity to realize tobacco harm reduction at the population level around the world,” the authors write in an introduction to the journal.
Juul Lab’s five-figure buyout of the journal issue is part of a public influence campaign that the Center for Responsive Politics tallied at more than $3.9 million in 2020 alone.
Juul Labs recently reached a legal settlement with the state of North Carolina in which it will pay $40 million to avoid a jury trial over the question of whether it illegally marketed nicotine products to teens.
You don’t have to be a doctor, or even play one on TV, to see the conflict: American healthcare policy that promotes taxpayer-funded needle exchanges for drug addicts, but opposes vaping as an alternative for smokers.
The Biden administration recently announced a robust plan to address the nation’s crippling opioid epidemic, which was responsible for 500,000 American deaths between 1999 and 2019. That harm reduction includes needle exchanges, long a controversial policy. In 1988, Congress barred the use of federal funding for needle exchange programs. In 2015, amid the growing opioid crisis, then-President Barack Obama signed the Consolidated Appropriations Act, “which modified the restriction on use of federal funds for distributing sterile needles or syringes,” and allowed for funding to be used for other services, but not syringes.
The Biden administration plan mentions “harm reduction” a total of 12 times and hopes to “enhance” and “support” emerging harm reduction efforts. Although attempting to tackle the opioid epidemic is an admirable goal, the administration is doing an about-face in terms of adult access to all harm reduction products, and they’re not the only ones.
Rhode Island lawmakers recently held hearings on a series of bills that would ban flavored tobacco substitutes like vaping products. But those same Ocean State legislators held a floor session for the final vote on a bill that would establish “harm reduction centers.” A spirited debate took place for nearly an hour. Ultimately the measure passed by a vote of 62-9.
Harm reduction centers for opioid users are a worthwhile goal, but it is overwhelmingly hypocritical for lawmakers to support government funding those, while simultaneously blocking adult access to tobacco harm reduction products including e-cigarettes, heat-not-burn, and smokeless tobacco.
It is the smoke in combustible cigarettes that is responsible for the damage wrought by tobacco. Tobacco harm reduction products eliminate that smoke while allowing adult users to access nicotine, which in itself is not the harmful component of cigarettes. The U.S. Food and Drug Administration (FDA) has noted that it is the “mix of chemicals – not nicotine – that causes serious disease and death in tobacco users.”
The FDA currently regulates vapor products. But the agency, which fought so hard to regulate these products, has yet to approve a single premarket tobacco product application for any e-cigarette product. During a U.S. House oversight subcommittee meeting last month, lawmakers urged the agency to not approve any flavored e-cigarette product to “protect youth.”
In the Rhode Island House hearing, a spokesman for Campaign for Tobacco-Free Kids (CTFK) urged lawmakers to ban flavored tobacco and vapor products while supporting lawmakers’ efforts in increasing access to clean syringes and opioid antagonist medications, including methadone.
This makes no sense.
Is anyone arguing that more Americans should smoke? Or that health policy should promote smoking? Of course not, just as needle exchange advocates aren’t hoping more people will get hooked on heroin. It’s simply an acknowledgment of human nature, and an effort to reduce harm.
The infamous anti-tobacco and vaping crusader Michael Bloomberg similarly supports opioid harm reduction, but not tobacco harm reduction. A recent New York Times article interviewed the director of drug use initiatives at Vital Strategies, a Bloomberg-backed “philanthropic group.” The director noted that harm reduction programs help persons “stay safe and healthy and alive first and foremost.” Since 2016, Vital Strategies has worked in tandem with the World Health Organization to ban adult access to tobacco harm reduction products. In 2019, the organization highlighted India’s ban on e-cigarettes as a victory. Bloomberg himself has donated $160 million over a three-year period to “fight flavored e-cigarettes.”
In Rhode Island, the CTFK spokesperson noted that opioid harm reduction programs don’t create new users. That may be true, but e-cigarettes create former smokers by helping adults quit smoking. Moreover, they don’t cost taxpayers a dime, and as a harm reduction product, they help to reduce health care and other smoking-related costs.
The FDA has the ability to save millions of lives by approving tobacco harm reduction products. They shouldn’t let misinformed entities and people like CTFK and Michael Bloomberg stand in the way of science and common sense.
E-cigarette use in Taiwan has tripled since 2018, reports The Taipei Times, citing a study by the Ministry of Health and Welfare’s Health Promotion Administration (HPA).
In 2018, e-cigarette use was at 0.6 percent; in 2020, that rate grew to 1.7 percent, according to the study, which looked at responses from 25,000 people 18 years and older.
The highest e-cigarette use rates were found in men ages 26 to 30, at 6.3 percent, and women ages 21 to 25, at 4.6 percent.
“To put this growth into perspective, use of traditional cigarettes grew only marginally over this period, from 13 percent in 2018 to 13.1 percent in 2020,” said Lu Meng-ying, HPA Tobacco Control Division official. “The situation needs urgent attention, especially as new e-cigarette users are almost all young people.”
Most respondents said they use e-cigarettes out of curiosity while 17.3 percent use them to quit smoking combustible cigarettes and 9.7 percent use them because friends use them.
Use of flavored tobacco products is increasing as well, from 8.2 percent in 2018 to 15.6 percent in 2020. Majority of the increase was seen in women.
“There are more than 1,200 additives used in flavored tobacco products, and the vast majority of them are chemically derived,” Lu said. “The goal of manufacturers is to prevent new smokers, especially young women, from being turned off by foul smells.” He added that the effects of long-term use of flavored products are not well understood.